Led by former Loxo Oncology CEO Josh Bilenker, the startup now has a trio of cancer drugs in early-stage testing and more ...
The life-science tools provider said Monday that the combined company would operate under the name Treeline Biosciences and trade on the Nasdaq under the ticker TRLN. The transaction values Standard ...
Treeline Biosciences, a well-funded cancer company that has raised more than $1 billion since its 2021 founding, is looking ...
Combined company to operate as Treeline Biosciences, advancing a deep pipeline of small molecule inhibitors, protein degraders and targeted ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
BOSTON (AP) — BOSTON (AP) — Standard BioTools Inc. (LAB) on Tuesday reported net income of $127.1 million in its first quarter. On a per-share basis, the Boston-based company said it had profit of 33 ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
BOSTON, Mass., April 21, 2026 (GLOBE NEWSWIRE)-- Standard BioTools Inc. (NASDAQ: LAB) today announced that it will publish its first quarter 2026 financial results on Tuesday, May 5, 2026, after U.S.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results